Free genetic testing, offered partially or fully subsidized by industry, may have trade-offs, and health systems in Canada must carefully weigh potential clinical, ethical, and legal considerations to protect patient data, authors argue in a CMAJ (Canadian Medical Association Journal) commentary https://www.cmaj.ca/lookup/doi/10.1503/cmaj.231588.
“Near- and long-term expansion in no-cost testing and industry partnership in genetics, with patient data as the commodity, is likely,” writes Kirsten Bartels, a genetic counsellor at Providence Health Care Heart Centre, St. Paul’s Hospital, Vancouver, British Columbia, with coauthors. “Commodification of data is not the norm in health care systems in Canada and should not be introduced without due consideration.”
Sponsored genetic testing is available for a variety of conditions, from neuromuscular to eye conditions, and must be ordered by a medical professional, like provincially funded genetic tests. Most of these sponsored tests are performed in the United States, and technologies and testing methods may differ from those used in Canada, with potentially different or incomplete results. Sponsored genetic testing can also include a wider range of genes for testing, which may cause additional harm.
As well, Canada has stringent privacy laws to protect patients, but these laws may not apply in countries where testing is conducted, which could leave patients vulnerable to being identified.
To help guide health care providers in Canada about using sponsored genetic testing, the commentary authors, as members of the Canadian College of Medical Geneticists and Canadian Association of Genetic Counsellors, recently published a position statement.
They end with a call to action for government and health organizations.
“We call on health care jurisdictions to consider this important issue urgently and to support the development of comprehensive guidance to help practitioners navigate this next generation of genetic testing and data sharing.”
JOURNAL
Canadian Medical Association Journal
DOI
10.1503/cmaj.231588
METHOD OF RESEARCH
Commentary/editorial
SUBJECT OF RESEARCH
People
ARTICLE TITLE
Free genetic testing is not free of clinical and ethical considerations
ARTICLE PUBLICATION DATE
29-Jul-2024
and connect with fellow professionals
At DoveMed, our utmost priority is your well-being. We are an online medical resource dedicated to providing you with accurate and up-to-date information on a wide range of medical topics. But we're more than just an information hub - we genuinely care about your health journey. That's why we offer a variety of products tailored for both healthcare consumers and professionals, because we believe in empowering everyone involved in the care process.
Our mission is to create a user-friendly healthcare technology portal that helps you make better decisions about your overall health and well-being. We understand that navigating the complexities of healthcare can be overwhelming, so we strive to be a reliable and compassionate companion on your path to wellness.
As an impartial and trusted online resource, we connect healthcare seekers, physicians, and hospitals in a marketplace that promotes a higher quality, easy-to-use healthcare experience. You can trust that our content is unbiased and impartial, as it is trusted by physicians, researchers, and university professors around the globe. Importantly, we are not influenced or owned by any pharmaceutical, medical, or media companies. At DoveMed, we are a group of passionate individuals who deeply care about improving health and wellness for people everywhere. Your well-being is at the heart of everything we do.
0 Comments
Please log in to post a comment.